Losan Pharma
Losan Pharma GmbH is a privately held German pharmaceutical CDMO founded in 1992, providing contract development, manufacturing (solids, semi-solids, liquids), analytical, serialization, and clinical trial supply services to Big Pharma, mid-size, and startup pharmaceutical clients, with products distributed in over 70 countries.
- Company typePrivate
- Founded1992
- HeadquartersNeuenburg, Germany
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Losan Pharma does
Losan Pharma GmbH is a privately held German Contract Development and Manufacturing Organization (CDMO) founded in 1992 and headquartered in Neuenburg am Rhein, with a second site in Eschbach in southern Baden. The company provides full-service pharmaceutical development, manufacturing, and analytical services to Big Pharma, mid-size pharma, and pharma startup clients, with medicinal products distributed in over 70 countries. It manufactures solids (tablets, capsules, pellets, effervescent tablets, stick packs), semi-solids (suppositories), and liquids (solutions, suspensions, emulsions) at batch sizes of 400L to 2000L and is approved for potent compounds up to OEL class 3b, including narcotics.
The company differentiates through a stack of proprietary and specialized pharmaceutical technologies: Hot Melt Extrusion for amorphisation of poorly soluble APIs, nanomilling for BCS Class II–IV compounds, mesoporous silica drug loading, spray drying, hot melt coating for taste masking, orodispersible and matrix tablet platforms, and a patented Vismon coating technology that improves patient swallowing of multiparticulates. Stick-pack packaging has been a focus for over 15 years across six packaging lines, and effervescent tablet manufacturing has been in place since 1994. Complementary services include clinical trial supply, serialization and track-and-trace under a Werum PAS-X MES integrated with GS1, Arvato CSDB, TraceLink, SAP, ZetesOlympus, and tracekey, artwork and prepress services, and a contract analytical laboratory using LabWare 8 LIMS and Thermo Fisher Chromeleon 7.2 CDS.
Losan Pharma operates a B2B enterprise field-sales model with contract-based pricing negotiated per project, has cleared inspections by FDA, ANVISA, Saudi-FDA, Turkish, and Russian authorities without an FDA Form 483, and is EcoVadis-certified for four consecutive years through 2025 and Great Place to Work-certified in 2023, 2024, and 2026. Leadership is held by General Managers Dr. Jens Morgenthaler and Dr. Stephan Motz, and the company is privately owned with no parent or external investment disclosed. Current strategic priorities include commissioning a new production facility in the Breisgau industrial park and a new logistics centre at the Eschbach Campus, both advancing in 2025.
Losan Pharma firmographics
Firmographics- Name
- Losan Pharma
- Legal name
- Losan Pharma GmbH
- Website
- https://losan-pharma.de
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Losan Pharma GmbH is a privately held German pharmaceutical CDMO founded in 1992, providing contract development, manufacturing (solids, semi-solids, liquids), analytical, serialization, and clinical trial supply services to Big Pharma, mid-size, and startup pharmaceutical clients, with products distributed in over 70 countries.
- Ownership category
- akta.pro rank
Losan Pharma industry classification
Industry- Product category
- Pharmaceutical Contract Development and Manufacturing (CDMO)
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)
Keywords
Where Losan Pharma is headquartered
LocationHeadquarters
- HQ city
- Neuenburg
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Losan Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Contract Development Services: Full-service pharmaceutical development from concept to commercialization including formulation development, analytical development, and clinical trial supply. Services available for over 25 years at the Neuenburg R&D facility.
- Contract Manufacturing Services: Manufacturing of pharmaceutical products including solids (tablets, capsules, effervescent tablets, pellets, stick packs), semi-solids (suppositories), and liquids (solutions, suspensions, emulsions) up to OEL class 3b.
- Analytical Services: Contract analysis including raw material testing, method development and validation, stability storage and testing under GMP and non-GMP conditions. Available since 2021 for all customers.
- Artwork Services: Print proof creation, prepress services, and packaging artwork coordination for pharmaceutical packaging materials including folding boxes, leaflets, labels, and blister films.
- Serialization Services: Track and trace implementation, serialisation, aggregation, and compliance with regulatory requirements for China, Europe, USA, and other markets.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Losan Pharma product offering
Product offeringCore offering
Losan Pharma is a German Contract Development and Manufacturing Organization (CDMO) providing full-service pharmaceutical development and manufacturing for solid, semi-solid, and liquid dosage forms. The company supports clients from concept to commercialization, including formulation development, analytical services, clinical trial supply, manufacturing, serialization, and artwork services, with products distributed in over 70 countries.
Product overview
Losan Pharma is a German Contract Development and Manufacturing Organisation (CDMO) offering one-stop-shop services for pharmaceutical development and manufacturing. The portfolio consists of three core service lines—Contract Development (formulation, analytical development, clinical trial supply), Contract Manufacturing (solids, semi-solids, liquids), and Analytical Services—supported by specialized technology platforms including Hot Melt Extrusion, Nanotechnology, Mesoporous Silica, Spray Drying, Stick Pack Technology, Orodispersible Technology, Matrix Tablets, Coating Technologies (film coating, Hot Melt Coating), Effervescent Tablets, Pellets, and Minitablets. Additional services include Serialization/Track & Trace, Artwork Services, and Clinical Trial Supply. The company serves global pharmaceutical partners with products distributed in over 70 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Contract Development Services Full-service pharmaceutical development from concept to commercialisation, including formulation development, analytical development, and clinical trial supply for solid, semi-solid, and liquid dosage forms. Designed for pharmaceutical companies requiring outsourced drug development expertise.
- Contract Manufacturing Services Manufacturing of medicinal products including solids (tablets, capsules, pellets, granules), semi-solids (suppositories), and liquids (solutions, suspensions, emulsions) distributed in over 70 countries, with serialization and artwork services bundled. Targets pharmaceutical companies needing CDMO manufacturing capacity.
- Analytical Services Contract analysis including raw material testing, method development and validation, stability storage, and GMP/non-GMP analytical testing using instruments such as HPLC, UPLC, gas chromatography, and in vitro drug release systems. Serves pharmaceutical companies needing outsourced analytical testing.
- Serialization Services Track and Trace serialization services covering serialisation, tamper evidence, and aggregation. All packaging lines equipped with GS1-compliant hardware and software for markets including China, EU, Saudi Arabia, USA, and Portugal. Serves pharmaceutical companies needing regulatory serialization compliance.
- Artwork Services GMP-compliant processing of print data for pharmaceutical packaging including folding boxes, packaging leaflets, labels, and blister/bag films, with digital print proof creation and prepress services. Serves pharmaceutical companies requiring packaging artwork coordination.
- Clinical Trial Supply Complete clinical trial manufacturing services from preclinical to Phase III, including bulk manufacturing, packaging, labeling, comparator sourcing, blinding, and worldwide distribution for all dosage forms. Serves pharmaceutical companies conducting clinical trials.
Quantifiable outcome
- Products distributed in over 70 countries
- +4 more outcomes
Companies that use Losan Pharma
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Losan Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
Feature12 records
Losan Pharma partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- Werum (PAS-X)coreLosan Pharma uses Werum's PAS-X as their Level 3 Track and Trace system since 2017. This validated system enables serial number generation, pre-serialised folding box handling, GS1 conformance, and automatic serial number exchange for pharmaceutical serialization requirements.
- Arvato CSDBcoreConnected to Arvato CSDB system for track and trace compliance and serialisation data management.
- TraceLinkcoreConnected to TraceLink network for pharmaceutical track and trace serialization compliance.
- SAPcoreIntegrated with SAP systems for serialization and supply chain data management.
- ZetesOlympuscoreConnected to ZetesOlympus system for track and trace serialization compliance.
- tracekeycoreConnected to tracekey platform for pharmaceutical serialization compliance.
- LabWarecoreLosan uses LabWare 8 as their LIMS (Laboratory Information Management System) for electronic sample management, analysis tracking, result management, and stability study management including individual results and stability reports.
- Thermo Fisher (Chromeleon)coreLosan uses Chromeleon 7.2 from Thermo Fisher as their CDS (Chromatography Data System), providing fast, standardised sequences and minimal error rates.
- GS1coreLosan Pharma is part of the global GS1 system since 2016 (via GLN - Global Location Number). Uses GS1 standards for product labeling with GTIN (Global Trade Item Number) for worldwide unique identification and GS1-128 for machine-readable coding. GS1 standards enable efficient traceability and track & trace compliance.
Scale indicators8 records
Recent moves8 records
Expansion highlights6 records
Losan Pharma competitors and assessment
Company assessmentDirect peers
- Aenova Group: Aenova is a leading German pharmaceutical CDMO with comparable mid-market scale, offering solid, semi-solid, and liquid dosage form development and manufacturing across multiple European sites. Highly comparable to Losan in customer base (Big Pharma and mid-size), technology breadth, and regulatory positioning.
- Siegfried Holding: Siegfried is a Swiss-listed pharmaceutical CDMO of comparable size offering API and drug product manufacturing services across solid and liquid dosage forms. Closely comparable business model, European footprint, and mix of Big Pharma customers to Losan.
- Recipharm: Recipharm is a Swedish-headquartered CDMO with a broad portfolio in solid, semi-solid, and sterile dosage forms, serving a similar mix of Big Pharma and mid-size pharma customers. Comparable mid-market scale and European manufacturing footprint to Losan.
- Hovione: Hovione is a Portuguese CDMO specializing in API development, particle engineering, and solid oral dosage forms, with strong technology platforms in spray drying, amorphous solid dispersions, and nanomilling. Closely comparable technology stack and bioavailability-focused positioning to Losan.
- Corden Pharma (International): Corden Pharma is a full-service CDMO offering APIs, excipients, and drug product manufacturing across multiple modalities, with strong presence in solids, semi-solids, and high-potency manufacturing. Comparable mid-market size and global pharmaceutical customer base to Losan.
- Fareva: Fareva is a privately held French-headquartered pharmaceutical CDMO offering contract manufacturing for solids, semi-solids, liquids, and sterile products across European sites. Comparable in scale, ownership profile, and European pharma customer mix to Losan.
- Almac Group: Almac is a Northern Ireland-headquartered CDMO offering pharmaceutical development, manufacturing, serialization, and clinical trial supply services to global pharma customers. Directly comparable mid-market scale, service breadth, and serialization/track-and-trade capabilities to Losan.
- PCI Pharma Services: PCI Pharma Services is a global CDMO specializing in clinical trial supply, commercial packaging, serialization, and drug product manufacturing. Directly comparable in serialization/track-and-trace capability and clinical-to-commercial supply chain services to Losan's CTM and serialisation offerings.
Broad incumbents
- Catalent: Catalent is one of the largest global CDMOs offering oral solids, sterile injectables, biologics, and cell/gene therapy services across many sites. Operates broadly in the same space as Losan but at vastly greater scale and with adjacent modalities (biologics, CGT) Losan does not offer.
- Patheon (Thermo Fisher Scientific): Patheon, part of Thermo Fisher's pharma services business, is a global incumbent CDMO offering API and drug product services across small molecules and biologics. Much larger than Losan with broader modality coverage and integrated analytical/instrumentation offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Losan Pharma social profiles
Digital presenceLosan Pharma compliance and trust
Trust signalCompliance6 records
Losan Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Losan Pharma leadership team
Management profileNumber of profiles
Profiles2 records
Losan Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Losan Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Losan Pharma
What does Losan Pharma do?
Losan Pharma is a German Contract Development and Manufacturing Organization (CDMO) providing full-service pharmaceutical development and manufacturing for solid, semi-solid, and liquid dosage forms. The company supports clients from concept to commercialization, including formulation development, analytical services, clinical trial supply, manufacturing, serialization, and artwork services, with products distributed in over 70 countries.
Is Losan Pharma a public or private company?
Losan Pharma is a private company. It is classified as unknown and is currently operating.
When was Losan Pharma founded?
Losan Pharma was founded in 1992. It employs 501 to 1,000 people.
Where is Losan Pharma based?
Losan Pharma is headquartered in Neuenburg, Germany, in the Europe region.
How does Losan Pharma make money?
Five revenue lines are on record. Contract Development Services are the primary driver. The others are contract Manufacturing Services, analytical Services, artwork Services and serialization Services.
Who are Losan Pharma's main competitors?
Direct peers on record are Aenova Group, Siegfried Holding, Recipharm, Hovione, Corden Pharma (International), Fareva, Almac Group and PCI Pharma Services. Broad incumbents are Catalent and Patheon (Thermo Fisher Scientific).
Does Losan Pharma have an API?
No public API is recorded for Losan Pharma.
What industry is Losan Pharma in?
Losan Pharma's product category is Pharmaceutical Contract Development and Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2834.